FDA Drug Recalls

Recalls / Class II

Class IID-0973-2017

Product

0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B1309, NDC: 0338-0049-38

Brand name
Sodium Chloride
Generic name
Sodium Chloride
Active ingredient
Sodium Chloride
Route
Intravenous
NDCs
0338-0043, 0338-0049
FDA application
NDA018016
Affected lot / code info
Lots: P361501, P361667, and P361790, Exp 09/30/18

Why it was recalled

Lack of Assurance of Sterility: Bags have the potential to leak.

Recalling firm

Firm
Baxter Healthcare Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Baxter Pkwy, Deerfield, Illinois 60015-4625

Distribution

Quantity
295,200 bags
Distribution pattern
Nationwide, Puerto Rico and Saudi Arabia

Timeline

Recall initiated
2017-07-06
FDA classified
2017-07-11
Posted by FDA
2017-07-19
Terminated
2020-04-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0973-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Sodium Chloride · FDA Drug Recalls